WhiteLab Genomics is a pioneering brand that specializes in the development of state-of-the-art software solutions using Artificial Intelligence (AI) to accelerate and de-risk gene and cell therapy breakthroughs. Their cutting-edge platform leverages graph knowledge technology and machine learning to help scientists discover and design innovative genomic therapies. By utilizing extensive datasets, their platform offers in-silico simulations, enabling the discovery and optimization of optimized payloads and vectors.

Thanks to WhiteLab Genomics' advanced software solutions and proprietary database, scientists in the field of genomic medicine can obtain precise and exhaustive answers to crucial scientific and technological questions. This includes optimizing payload and vector design, assessing genotoxicity, and identifying optimal experimental protocols for in vivo and in vitro strategies. WhiteLab Genomics focuses on three therapeutic fields: gene therapy, RNA therapy, and cell therapy.

Their solutions enable the introduction or modification of genetic material to correct genetic disorders, activate therapeutic effects, or trigger medicinal effects through the injection or implantation of transformed cells. By merging computer sciences and biology, WhiteLab Genomics empowers their customers to develop genomic medicines more efficiently and make revolutionary treatments more accessible to patients in need. Their technology reduces the development time of biotherapies, leading to faster market access and more cost-effective therapeutic solutions.

Connect with WhiteLab Genomics today and revolutionize the future of genomic medicine